Cart
sales@molnova.com
TBTA
CAS No. 510758-28-8
TBTA( —— )
Catalog No. M18691 CAS No. 510758-28-8
TBTA is a tertiary amine with three 1, 2, 3-triazole groups. It complexes with, and stabilizes, copper(I) to accelerate azide-alkyne cycloadditions, as used in click chemistry.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 43 | In Stock |
|
| 25MG | 70 | In Stock |
|
| 50MG | 97 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTBTA
-
NoteResearch use only, not for human use.
-
Brief DescriptionTBTA is a tertiary amine with three 1, 2, 3-triazole groups. It complexes with, and stabilizes, copper(I) to accelerate azide-alkyne cycloadditions, as used in click chemistry.
-
DescriptionTBTA is a tertiary amine with three 1, 2, 3-triazole groups. It complexes with, and stabilizes, copper(I) to accelerate azide-alkyne cycloadditions, as used in click chemistry.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number510758-28-8
-
Formula Weight530.62
-
Molecular FormulaC30H30N10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (188.46 mM)
-
SMILESC(N(Cc1cn(Cc2ccccc2)nn1)Cc1cn(Cc2ccccc2)nn1)c1cn(Cc2ccccc2)nn1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hong V, et al. Electrochemically Protected Copper(I)-Catalyzed Azide-Alkyne Cycloaddition[J]. Chembiochem, 2008, 9(9):1481-1486.
molnova catalog
related products
-
HIV-gp120-41-N-A
HIV-gp120-41-N-A
-
Mogroside III-A2
Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.
-
Crizanlizumab
Crizanlizumab (Adakveo) is a humanized monoclonal antibody against P-selectin for the prevention of pain crises in sickle cell disease.
